Dr. Thomas Wang is the chief of the Division of Cardiovascular Medicine at Vanderbilt University, and the Physician-in-Chief of the Vanderbilt Heart and Vascular Institute. He is the inaugural holder of the Gottlieb C. Friesinger II Chair in Cardiovascular Medicine.
Dr. Wang is a graduate of Harvard College and Harvard Medical School. He completed his residency and cardiology fellowship training at the Massachusetts General Hospital. After a post-doctoral research fellowship at the Framingham Heart Study, he was a member of the faculty of the Massachusetts General Hospital and Harvard Medical School between 2003 and 2013.
His research focuses on the role of the natriuretic peptide system in cardiovascular health, the identification of novel biomarkers, and mechanisms of obesity-related cardiac dysfunction. His group has experience in a variety of approaches to patient-oriented research, from population-based cohort studies to physiologic interventions and randomized controlled trials. This work has been continuously funded by the NIH. In each of the past 4 years, Dr. Wang has been named to the Most Highly-Cited Researchers list by Thomson Reuters (top 1% most cited). He has published more than 245 original articles. He is the founding director of the Vanderbilt Translational and Clinical Cardiovascular Research Center (VTRACC).
Dr. Wang has trained numerous fellows and junior faculty members. He received the Partners Healthcare Outstanding Mentor Award in 2012 (Partners is the parent organization of the Massachusetts General Hospital and Brigham and Women’s Hospital). He presently serves as the PI of the cardiovascular research training grant at Vanderbilt, in its 38th year.
Dr. Wang has been elected to the American Society of Clinical Investigation (ASCI), the Association of American Physicians (AAP), and the Association of University Cardiologists (AUC). He is the President-elect of the Association of Professors of Cardiology (APC). He serves on the Observational Safety Monitoring Boards for the Atherosclerosis Risk in Communities (ARIC) study and the Nulliparous Pregnancy Outcomes Study Monitoring Mothers-to-be (nuMoM2b) Heart Health Study. He has served on numerous leadership committees of the American Heart Association, including the AHA Council on Functional Genomics and Translational Biology (Chair), the Epidemiology and Prevention Council (leadership committee), and the AHA National Research Committee (member). He is the chair of the AHA Open Science Committee. He is a past chair of the AHA Genomics, Translational Biology, and Observational Epidemiology study section. He is a Senior Associate Editor of the Journal of the American Heart Association.
This website is optimized for Chrome and Internet Explorer 11.